EFTA Document EFTA01356332
D & D Funding II, LLC Andrew Gallivan 2/28/2017 This company is a Joint Venture entity created owned 50/50 by Chris Diamantis and Joe Dinardo. Both Chris and Joe's wealth come from their own businesses and they use this company for joint ventures in various companies and assets. This entity is used solely as an investment vehicle; currently hold —$4MM at DB No No Joanne Jensen Winklevoss Index, LLC Andrew Gallivan 2/27/2017 This entity is owned by the Winklevoss
Summary
D & D Funding II, LLC Andrew Gallivan 2/28/2017 This company is a Joint Venture entity created owned 50/50 by Chris Diamantis and Joe Dinardo. Both Chris and Joe's wealth come from their own businesses and they use this company for joint ventures in various companies and assets. This entity is used solely as an investment vehicle; currently hold —$4MM at DB No No Joanne Jensen Winklevoss Index, LLC Andrew Gallivan 2/27/2017 This entity is owned by the Winklevoss
Ask AI About This Document
Extracted Text (OCR)
Related Documents (6)
EFTA Document EFTA01438073
Clients+Products Contact Information KCP AFS communication Events/ Entertainment General Information Current Offerings Offerings September Offerings Relationship Name Claimed? C/P/I Private Markets Focus To Do Suntex AcTRS RESOF Proton Phoenix Research Focus Risk Factors Notes To Do Interest Notes MS Buffered Jump Plu MS Apple Autocall MS Crude Oil Autocall HSBC SXSE Buffered Accelerated Return CS XOP Accelereated Return CS SPX Callable JP SPX Twin Win MS SPX Buffere
EFTA Document EFTA01428714
Subject: RE: MD approval for ACUs completed for High Risk Clients [I] From: Vaishali-P Mehta Date: Wed, 05 Apr 2017 13:16:38 -0400 To: Joanne Jensen Andrew Gallivan Cc: Mark Gonzalez Rachel Maglicic Stewart Oldfield Brian P Conve Jennifer Shay Andrea Nicoletti Rosemary Vrablic Mary A Coleman Terrence F Tan Terri Sohra Classification: For internal use only Hi Joanne I fully understand. Thankfully this is the last of the emails as going forward we will have KYC updates which wil
EFTA Document EFTA01433607
Clients+Products Contact Information KCP AFS communication Events/ Entertainment General Information Current Offerings Offerings September Offerings Relationship Name Family Office Name Claimed? C/P/I Email Phone Address Private Markets Focus Capital Markets Focus To Do Suntex AcTRS RIN Retrofit RESOF Proton Phoenix Lease Monetization Focus Risk Factors Notes To Do Interest Plu MS Apple Autocall MS Crude Oil Autocall Accelerated Return CS XOP Accelereated Return
EFTA Document EFTA01438221
Clients+Products Contact Information rtainment General Information Relationship Name e Address City us Notes To Do Suntex AcTRS RIN Retrofit ABR Astra Extell RESOF Prot on Phoenix AFS Focus Research Focus Risk Factors Notes To Do Interest Notes MS B uffered Jump Plus (9/25) MS Apple Autocall (9/18) MS Crude Oil Autocall (9/14) HSBC SXSE Buffered Accelerated Return (9/24) CS XOP Accelereated Return Barrier (9/18) CS S PX Callable (9/25) JP SPX Twin Win (9/25) CIO Vi
EFTA Document EFTA01398793
Subject: RE: MD approval for ACUs completed for High Risk Clients [I] From: Andrew Gallivan Date: Fri, 07 Apr 2017 To: Vaishali-P Mehta < Classification: For internal use only Approved. From: Vaishali-P Mehta Sent: Friday, April 07, 2017 2:21 PM To: Andrew Gallivan Subject: FW: MD approval for ACUs completed for High Risk Clients [I] Classification: For internal use only Hi Andrew, In an effort to ensure that you have to approve only 1 email, I sent the below email, in hindsight I s
EFTA Document EFTA01437665
Clients+Products Contact Information KCP AFS Structured Notes rtainment General Information Current Offerings General Current Offerings September Offerings Relationship Name Family Office Name First Last Claimed? C/P/I Email Phon e Address City State Zip Private Markets Focus Capital Markets Focus Research Foc us Notes To Do Suntex AcTRS RIN Retrofit ABR Astra Extell RESOF Prot on Phoenix AFS Focus Research Focus Risk Factors Notes To Do Interest Notes MS
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.